The protective effect on peritoneum of L－carnitine and its lower alkanoyl derivatives, both in the form of inner or pharmaceutically acceptable salts is disclosed. Concentrations of carnitine from about 0.02 to 0.5% w/v are suitable for preparing a solution for peritoneal dialysis having higher biocompatibility and protecting peritoneum from toxic effects of continuous use of solutions for peritoneal dialysis, in particular ones containing glucose as osmotic agent. A particularly preferred embodiment is a solution for peritoneal dialysis containing carnitine, glucose and xylitol.Rastvor za peritonealnu dijalizu koji sadrži od 0,02 % procentne koncentracije do 0,5 % procentne koncentracije L-karnitina, ksilotola i glukoze.Prijava sadrži još 14 patentnih zahteva.
